Det kan se lovende ut, men merk at dette er innledende resultater fra en ikke-klinisk studie, og flere andre midler som har virket bra mot virus direkte, har hatt liten eller ingen virkning når det gis som medikament.
Mer rundt dette her (mine uthevinger): https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/
Mer rundt dette her (mine uthevinger): https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/
QuoteJapanese trading and pharmaceuticals company Kowa Co Ltd on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non-clinical research.
...
The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.
...
Many potential COVID-19 treatments that showed promise in test tubes, (...) failed to show benefit for COVID-19 patients once studied in clinical trials.